NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 115 filers reported holding NURIX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,264 | -81.8% | 9,830 | -76.9% | 0.00% | -66.7% |
| Q2 2023 | $425,098 | +93.9% | 42,552 | +72.4% | 0.00% | +200.0% |
| Q1 2023 | $219,236 | -87.2% | 24,689 | -81.3% | 0.00% | -90.0% |
| Q3 2022 | $1,719,000 | +97.6% | 131,919 | +92.1% | 0.01% | +100.0% |
| Q2 2022 | $870,000 | +4.2% | 68,684 | +15.3% | 0.01% | -28.6% |
| Q1 2022 | $835,000 | +92.0% | 59,581 | +296.8% | 0.01% | +75.0% |
| Q4 2021 | $435,000 | +29.5% | 15,014 | +18.6% | 0.00% | 0.0% |
| Q2 2021 | $336,000 | +31.8% | 12,663 | +54.4% | 0.00% | +33.3% |
| Q1 2021 | $255,000 | – | 8,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 15,823 | $163,293 | 0.00% |